Y Intercept Hong Kong Ltd lifted its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 167.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 40,018 shares of the medical research company's stock after acquiring an additional 25,034 shares during the period. Y Intercept Hong Kong Ltd's holdings in Agilent Technologies were worth $4,681,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Redwood Park Advisors LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at about $27,000. Lee Danner & Bass Inc. purchased a new stake in Agilent Technologies during the 4th quarter worth approximately $29,000. Whipplewood Advisors LLC increased its holdings in Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after purchasing an additional 186 shares during the last quarter. Sunbelt Securities Inc. increased its holdings in Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock worth $30,000 after purchasing an additional 192 shares during the last quarter. Finally, Opal Wealth Advisors LLC purchased a new stake in Agilent Technologies during the 1st quarter worth approximately $31,000.
Insider Buying and Selling at Agilent Technologies
In related news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares in the company, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Analyst Upgrades and Downgrades
Several brokerages have recently commented on A. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, June 28th. Wells Fargo & Company reduced their price objective on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research report on Thursday, April 17th. Robert W. Baird reduced their price objective on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. JPMorgan Chase & Co. reduced their price objective on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a research report on Thursday, May 29th. Finally, UBS Group reduced their price target on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday, May 29th. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $139.77.
Get Our Latest Analysis on A
Agilent Technologies Trading Down 0.0%
Shares of A stock traded down $0.05 during trading hours on Friday, reaching $120.30. The company had a trading volume of 975,854 shares, compared to its average volume of 2,038,360. The company has a 50 day moving average of $116.32 and a 200 day moving average of $121.67. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.60. The firm has a market cap of $34.17 billion, a price-to-earnings ratio of 29.66, a P/E/G ratio of 3.62 and a beta of 1.23. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84.
Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.26 by $0.05. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The firm's revenue was up 6.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.22 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.
Agilent Technologies Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st were issued a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.82%. The ex-dividend date of this dividend was Tuesday, July 1st. Agilent Technologies's payout ratio is 24.44%.
Agilent Technologies Company Profile
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
See Also

Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.